相似文献
1
Static and dynamic properties of the HCM myocardium.
J Mol Cell Cardiol. 2010 Nov;49(5):715-8. doi: 10.1016/j.yjmcc.2010.07.016. Epub 2010 Aug 10.
2
Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy.
J Mol Cell Cardiol. 2010 Nov;49(5):737-45. doi: 10.1016/j.yjmcc.2010.06.006. Epub 2010 Jul 6.
3
Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
J Am Heart Assoc. 2014 Nov 11;3(6):e001263. doi: 10.1161/JAHA.114.001263.
4
The absence of pathological myofibre disarray in the diabetic heart: is it a paradox?
Acta Cardiol. 2009 Apr;64(2):267-8. doi: 10.2143/AC.64.2.2036148.
5
Myocardial structure and left ventricular function in hypertrophic and dilative cardiomyopathy and aortic valve disease.
Z Kardiol. 1987;76 Suppl 3:9-13.
6
Hypertrophic cardiomyopathy: an autopsy analysis of 14 cases.
J Postgrad Med. 2001 Jul-Sep;47(3):165-70.
7
Myofilament protein dynamics modulate EAD formation in human hypertrophic cardiomyopathy.
Prog Biophys Mol Biol. 2017 Nov;130(Pt B):418-428. doi: 10.1016/j.pbiomolbio.2017.06.015. Epub 2017 Jun 22.
8
Evaluation of DNA content by static cytometry in hypertrophic cardiomyopathy (HCM).
Ann N Y Acad Sci. 1995 Mar 27;752:202-3. doi: 10.1111/j.1749-6632.1995.tb17423.x.
9
Evolution and clinical importance of fibrosis in HCM.
JACC Cardiovasc Imaging. 2011 Nov;4(11):1221-3. doi: 10.1016/j.jcmg.2011.04.023.
10
Hypertrophic obstructive cardiomyopathy of the left ventricle (idiopathic hypertrophic subaortic stenosis).
Cardiovasc Clin. 1972;4(1):133-65.
引用本文的文献
1
Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle.
Int J Mol Sci. 2018 Jul 31;19(8):2234. doi: 10.3390/ijms19082234.
本文引用的文献
1
Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy.
J Mol Cell Cardiol. 2010 Nov;49(5):737-45. doi: 10.1016/j.yjmcc.2010.06.006. Epub 2010 Jul 6.
2
Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.
J Mol Cell Cardiol. 2010 May;48(5):899-909. doi: 10.1016/j.yjmcc.2010.03.005. Epub 2010 Mar 16.
3
PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness.
Circ Res. 2009 Sep 25;105(7):631-8, 17 p following 638. doi: 10.1161/CIRCRESAHA.109.198465. Epub 2009 Aug 13.
4
Titin-based mechanical signalling in normal and failing myocardium.
J Mol Cell Cardiol. 2009 Apr;46(4):490-8. doi: 10.1016/j.yjmcc.2009.01.004.
5
Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction.
Circulation. 2009 Mar 24;119(11):1473-83. doi: 10.1161/CIRCULATIONAHA.108.838672. Epub 2009 Mar 9.
6
Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium.
Circ Res. 2009 Mar 27;104(6):780-6. doi: 10.1161/CIRCRESAHA.108.193326. Epub 2009 Jan 29.
7
Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.
FASEB J. 2009 Mar;23(3):855-65. doi: 10.1096/fj.08-118182. Epub 2008 Nov 5.
8
Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes.
Biochem Biophys Res Commun. 2008 Nov 7;376(1):80-5. doi: 10.1016/j.bbrc.2008.08.084. Epub 2008 Aug 26.
9
Heterogeneity of regional systolic function detected by tissue Doppler imaging is linked to impaired global left ventricular relaxation in hypertrophic cardiomyopathy.
Heart. 2008 Oct;94(10):1302-6. doi: 10.1136/hrt.2007.124453. Epub 2008 Jan 15.
10
Sarcomeric proteins and inherited cardiomyopathies.
Cardiovasc Res. 2008 Mar 1;77(4):659-66. doi: 10.1093/cvr/cvm084. Epub 2007 Dec 4.
Zotero 插件